Moxisylyte

  • TRADE NAMES: Erecnos; Icavex; Opilon (Concord)
  • INDICATIONS: Impotence, primary Raynaud's phenomenon
  • SYNONYM: Thymoxamine (British Approved Name)
  • CLASS: Alpha-adrenergic channel blocker
  • HALF-LIFE: 1–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Acebutolol, Alfuzosin, Captopril, Cilazapril, Enalapril, Fosinopril, Indoramin, Irbesartan, Lisinopril, Olmesartan, Quinapril, Ramipril, Trandolapril, Tricyclic antidepressants

Our database has 9 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
OCULAR.
RESPIRATORY.


Page last updated 07/31/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top